Page last updated: 2024-09-04

moxifloxacin and Dyspepsia

moxifloxacin has been researched along with Dyspepsia in 3 studies

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's2 (66.67)29.6817
2010's1 (33.33)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Cataldi, V; Cellini, L; Ciccaglione, AF; Di Bartolomeo, S; Di Campli, E; Di Giulio, M; Grossi, L; Marzio, L; Nostro, A1
Cammarota, G; Candelli, M; Cazzato, IA; Cremonini, F; Finizio, R; Gasbarrini, A; Gasbarrini, G; Nista, EC; Ojetti, V; Pignataro, G; Santoro, M; Zocco, MA1
Altintaş, E; Sezgin, O; Tellioğlu, B; Tombak, A; Uçbilek, E1

Trials

2 trial(s) available for moxifloxacin and Dyspepsia

ArticleYear
Moxifloxacin-based strategies for first-line treatment of Helicobacter pylori infection.
    Alimentary pharmacology & therapeutics, 2005, May-15, Volume: 21, Issue:10

    Topics: Adult; Amoxicillin; Aza Compounds; Drug Therapy, Combination; Dyspepsia; Esomeprazole; Female; Fluoroquinolones; Helicobacter Infections; Helicobacter pylori; Humans; Male; Middle Aged; Moxifloxacin; Patient Compliance; Prospective Studies; Quinolines; Tinidazole; Treatment Outcome

2005
Low efficacy rate of moxifloxacin-containing Helicobacter pylori eradication treatment: in an observational study in a Turkish population.
    Helicobacter, 2007, Volume: 12, Issue:5

    Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adolescent; Adult; Aged; Amoxicillin; Anti-Infective Agents; Anti-Ulcer Agents; Aza Compounds; Drug Therapy, Combination; Dyspepsia; Female; Fluoroquinolones; Helicobacter Infections; Helicobacter pylori; Humans; Male; Middle Aged; Moxifloxacin; Pantoprazole; Peptic Ulcer; Pilot Projects; Quinolines; Treatment Outcome; Turkey

2007

Other Studies

1 other study(ies) available for moxifloxacin and Dyspepsia

ArticleYear
In vitro antimicrobial susceptibility of Helicobacter pylori to nine antibiotics currently used in Central Italy.
    Scandinavian journal of gastroenterology, 2016, Volume: 51, Issue:3

    Topics: Adolescent; Adult; Aged; Aged, 80 and over; Amoxicillin; Ampicillin; Anti-Bacterial Agents; Child; Ciprofloxacin; Clarithromycin; Drug Resistance, Multiple, Bacterial; Dyspepsia; Female; Fluoroquinolones; Gastric Fundus; Helicobacter Infections; Helicobacter pylori; Humans; Italy; Levofloxacin; Male; Metronidazole; Microbial Sensitivity Tests; Middle Aged; Moxifloxacin; Pyloric Antrum; Rifabutin; Tetracycline; Young Adult

2016